4.11Open4.11Pre Close0 Volume24 Open Interest12.50Strike Price0.00Turnover155.42%IV2.78%PremiumOct 18, 2024Expiry Date3.87Intrinsic Value100Multiplier13DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type-0.8698Delta0.0859Gamma2.16Leverage Ratio-0.0193Theta-0.0031Rho-1.88Eff Leverage0.0034Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet